Virtu Financial’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,574
| Closed | -$31K | – | 2076 |
|
|
2025
Q1 | $31K | Buy |
+19,574
| New | +$31K | ﹤0.01% | 1069 |
|
|
2024
Q2 | – | Sell |
-16,199
| Closed | -$50K | – | 1931 |
|
|
2024
Q1 | $50K | Buy |
+16,199
| New | +$50K | ﹤0.01% | 1029 |
|
|
2022
Q4 | – | Sell |
-3,415
| Closed | -$14K | – | 2183 |
|
|
2022
Q3 | $14K | Sell |
3,415
-187
| -5% | -$767 | ﹤0.01% | 1477 |
|
|
2022
Q2 | $25K | Buy |
3,602
+2,235
| +163% | +$15.5K | ﹤0.01% | 1289 |
|
|
2022
Q1 | $16K | Sell |
1,367
-8,371
| -86% | -$98K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $179K | Buy |
9,738
+3,720
| +62% | +$68.4K | 0.02% | 876 |
|
|
2021
Q3 | $151K | Buy |
+6,018
| New | +$151K | 0.01% | 1007 |
|
|
2021
Q2 | – | Sell |
-755
| Closed | -$93K | – | 2124 |
|
|
2021
Q1 | $93K | Sell |
755
-166
| -18% | -$20.4K | 0.01% | 1338 |
|
|
2020
Q4 | $105K | Sell |
921
-849
| -48% | -$96.8K | 0.01% | 1042 |
|
|
2020
Q3 | $212K | Buy |
+1,770
| New | +$212K | 0.04% | 578 |
|
|
2019
Q4 | $59K | Buy |
+176
| New | +$59K | 0.01% | 1182 |
|
|
2018
Q4 | – | Sell |
-178
| Closed | -$126K | – | 2021 |
|
|
2018
Q3 | $126K | Buy |
+178
| New | +$126K | 0.01% | 1149 |
|